The other selected extracellular tumour marker candidate, ADAMTS16, a matrisome-associated protease, targets fibronectin to inhibit ECM assembly (50), further suggesting that ECM organisation is dysregulated in NSCLC tissue. Here, ADAMTS16 is linked to non-small cell lung carcinoma.